Cargando…
Prevalence Study of Dermatologic Manifestations among Diabetic Patients
BACKGROUND: Diabetes mellitus (DM) is an interdisciplinary disorder that needs many different specialties' attention; however, the importance of dermatologists' knowledge has not been highlighted regarding this issue. As a result, we aim to assess the prevalence and variety of DM skin and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6634127/ https://www.ncbi.nlm.nih.gov/pubmed/31355008 http://dx.doi.org/10.1155/2019/5293193 |
_version_ | 1783435748965351424 |
---|---|
author | Azizian, Zahra Behrangi, Elham Hasheminasabzavareh, Roshanak Kazemlo, Hassan Esmaeeli, Roja Hassani, Parvaneh |
author_facet | Azizian, Zahra Behrangi, Elham Hasheminasabzavareh, Roshanak Kazemlo, Hassan Esmaeeli, Roja Hassani, Parvaneh |
author_sort | Azizian, Zahra |
collection | PubMed |
description | BACKGROUND: Diabetes mellitus (DM) is an interdisciplinary disorder that needs many different specialties' attention; however, the importance of dermatologists' knowledge has not been highlighted regarding this issue. As a result, we aim to assess the prevalence and variety of DM skin and nail manifestations in an effort to further acquaint dermatologists and other clinicians with diabetic dermatologic manifestations. METHODS: This was a cross-sectional study; subjects who had a diagnosis of DM, attending to the outpatient endocrinology clinics of Rassoul Akram Hospital, Tehran, Iran, were evaluated by one dermatologist for diabetic dermopathy. The results were recorded in prepared data sheets, and general descriptions of DM duration, DM type, DM control, and drug history as well as the demographic data were gathered. RESULTS: Among a total of 255 subjects, the prevalence of one or more identifiable skin conditions was 88.4%. 15.7% of the subjects had nail manifestations. Among cutaneous manifestations, acanthosis nigricans, acral erythema, and onychoschizia showed a significant relationship with the age and disease duration (p<0.05); and knuckle pebbles, eczema, facial erythema, and koilonychias had a meaningful relationship with FBS level and glycated hemoglobin, HbA1c (p<0.05). CONCLUSION: This study provides an overview that facilitates earlier detection and treatment of DM. Also, this data can help physicians and endocrinologists to visualize DM control level. |
format | Online Article Text |
id | pubmed-6634127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-66341272019-07-28 Prevalence Study of Dermatologic Manifestations among Diabetic Patients Azizian, Zahra Behrangi, Elham Hasheminasabzavareh, Roshanak Kazemlo, Hassan Esmaeeli, Roja Hassani, Parvaneh Adv Prev Med Research Article BACKGROUND: Diabetes mellitus (DM) is an interdisciplinary disorder that needs many different specialties' attention; however, the importance of dermatologists' knowledge has not been highlighted regarding this issue. As a result, we aim to assess the prevalence and variety of DM skin and nail manifestations in an effort to further acquaint dermatologists and other clinicians with diabetic dermatologic manifestations. METHODS: This was a cross-sectional study; subjects who had a diagnosis of DM, attending to the outpatient endocrinology clinics of Rassoul Akram Hospital, Tehran, Iran, were evaluated by one dermatologist for diabetic dermopathy. The results were recorded in prepared data sheets, and general descriptions of DM duration, DM type, DM control, and drug history as well as the demographic data were gathered. RESULTS: Among a total of 255 subjects, the prevalence of one or more identifiable skin conditions was 88.4%. 15.7% of the subjects had nail manifestations. Among cutaneous manifestations, acanthosis nigricans, acral erythema, and onychoschizia showed a significant relationship with the age and disease duration (p<0.05); and knuckle pebbles, eczema, facial erythema, and koilonychias had a meaningful relationship with FBS level and glycated hemoglobin, HbA1c (p<0.05). CONCLUSION: This study provides an overview that facilitates earlier detection and treatment of DM. Also, this data can help physicians and endocrinologists to visualize DM control level. Hindawi 2019-07-01 /pmc/articles/PMC6634127/ /pubmed/31355008 http://dx.doi.org/10.1155/2019/5293193 Text en Copyright © 2019 Zahra Azizian et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Azizian, Zahra Behrangi, Elham Hasheminasabzavareh, Roshanak Kazemlo, Hassan Esmaeeli, Roja Hassani, Parvaneh Prevalence Study of Dermatologic Manifestations among Diabetic Patients |
title | Prevalence Study of Dermatologic Manifestations among Diabetic Patients |
title_full | Prevalence Study of Dermatologic Manifestations among Diabetic Patients |
title_fullStr | Prevalence Study of Dermatologic Manifestations among Diabetic Patients |
title_full_unstemmed | Prevalence Study of Dermatologic Manifestations among Diabetic Patients |
title_short | Prevalence Study of Dermatologic Manifestations among Diabetic Patients |
title_sort | prevalence study of dermatologic manifestations among diabetic patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6634127/ https://www.ncbi.nlm.nih.gov/pubmed/31355008 http://dx.doi.org/10.1155/2019/5293193 |
work_keys_str_mv | AT azizianzahra prevalencestudyofdermatologicmanifestationsamongdiabeticpatients AT behrangielham prevalencestudyofdermatologicmanifestationsamongdiabeticpatients AT hasheminasabzavarehroshanak prevalencestudyofdermatologicmanifestationsamongdiabeticpatients AT kazemlohassan prevalencestudyofdermatologicmanifestationsamongdiabeticpatients AT esmaeeliroja prevalencestudyofdermatologicmanifestationsamongdiabeticpatients AT hassaniparvaneh prevalencestudyofdermatologicmanifestationsamongdiabeticpatients |